GeneDx Holdings News

TD Cowen Adjusts GeneDx Holdings' Price Target to $24 From $14, Keeps Buy Rating

MT NewswiresApr 30 23:22

TD Cowen: Maintains GeneDx Hldgs (WGS.US) rating, adjusted from buy to buy rating, and adjusted target price from $14.00 to $24.00.

Zhitong FinanceApr 30 23:20

GeneDx Hldgs Analyst Ratings

BenzingaApr 30 19:42

BTIG Maintains Buy on GeneDx Hldgs, Raises Price Target to $19

BenzingaApr 30 19:43

GeneDx Holdings (WGS) Receives a Buy From BTIG

TipRanksApr 30 18:26

BTIG Maintains Buy on GeneDx Hldgs, Raises Price Target to $15

BenzingaApr 23 01:34

GeneDx Hldgs Analyst Ratings

BenzingaApr 15 22:23

Goldman Sachs Maintains Neutral on GeneDx Hldgs, Raises Price Target to $11

BenzingaApr 15 22:24

GeneDx Holdings (WGS) Gets a Buy From TD Cowen

TipRanksMar 28 19:15

Analysts Offer Insights on Healthcare Companies: GeneDx Holdings (WGS) and Glaukos (GKOS)

TipRanksFeb 22 18:30

Analysts Offer Insights on Healthcare Companies: Bicycle Therapeutics (BCYC), GeneDx Holdings (WGS) and Halozyme (HALO)

TipRanksFeb 21 14:11

GeneDx Holdings (WGS) Gets a Buy From BTIG

TipRanksJan 2 22:55

BTIG Sticks to Its Buy Rating for GeneDx Holdings (WGS)

TipRanksDec 31, 2023 18:28

Goldman Sachs Maintains Neutral on GeneDx Hldgs, Lowers Price Target to $6

BenzingaNov 1, 2023 21:27

GeneDx Hldgs Analyst Ratings

BenzingaNov 1, 2023 21:25

Analysts Offer Insights on Healthcare Companies: Sarepta Therapeutics (SRPT), GeneDx Holdings (WGS) and Protalix (PLX)

TipRanksOct 31, 2023 18:40

Goldman Sachs Maintains Neutral on GeneDx Hldgs, Lowers Price Target to $7

BenzingaAug 9, 2023 23:47

GeneDx Hldgs Analyst Ratings

BenzingaAug 9, 2023 23:47

GeneDx Holdings (WGS) Receives a Buy From BTIG

TipRanksJul 28, 2023 18:05

Goldman Sachs Maintains Neutral on GeneDx Hldgs, Lowers Price Target to $8

BenzingaJul 24, 2023 20:14